MAPK8 and cancer: Hyperactivation of the JNK proteins has been reported in multiple cancer cell lines and tissue samples, which evokes downstream pathway of drug resistance to escape apoptosis in a range of human cancers, including hepatocellular carcinoma, lung adenocarcinoma, colon carcinoma, or trip‐negative breast cancer 21, 22, 23, 24, 25.